Voloridge Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.9M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $878K | Sell |
|
|||||
|
2023
Q1 | $4.83M | Buy |
|
|||||
|
2022
Q4 | $3.98M | Buy |
|
|||||
|
2022
Q3 | $733K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.91M | Sell |
|
|||||
|
2021
Q4 | $4.02M | Buy |
|
|||||
|
2021
Q3 | $1.06M | Sell |
|
|||||
|
2021
Q2 | $2.71M | Buy |
|
|||||
|
2021
Q1 | $524K | Sell |
|
|||||
|
2020
Q4 | $1.6M | Buy |
|
|||||
|
2020
Q3 | $878K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $924K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.42M | Buy |
|